Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

Discover how this diabetes drug is revolutionizing heart health. Learn about its surprising benefits in reducing cardiovascular risks and mortality.

Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

The diabetes medication Ozempic has emerged as an unexpected player in the weight loss arena, sparking intense debate within medical communities about its broader effects on patient health.

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Popular drugs for diabetes and weight loss could have an unexpected side effect. Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity ...

A new study has found a medication already used to treat people who have type 2 diabetes and/or chronic kidney disease with added heart disease risks also helps lower their stroke and heart attack ...

South Carolina Attorney General Alan Wilson announced he is leading 37 states on a territory bipartisan coalition requesting ...

However, typically, type 2 diabetes is treated with medication plus lifestyle modifications. The following article includes several classes of medications that treat type 2 diabetes. Each class works ...